Summa Equity Acquires Majority Stake in Axion BioSystems
July 15, 2021
Summa Equity Fund II has acquired a majority stake in Axion BioSystems, a US life science tools company that develops MEA (microelectrode array) and impedance-based bioelectronic assay technologies. Summa plans to support Axion's commercial scale-up and global growth to accelerate adoption of its platforms across academia and biopharma, particularly in cell and gene therapy and drug discovery applications.
- Buyers
- Summa Equity
- Targets
- Axion BioSystems
- Industry
- Medical Devices
- Location
- Georgia, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Summa Equity Acquires Majority Stake in Sengenics
October 14, 2020
Biotechnology
Summa Equity Fund II has acquired a majority stake in Sengenics, a functional proteomics company that commercialises the KREX technology for full‑length, correctly folded protein production and autoantibody detection. The investment will support Sengenics' product development, global expansion and accelerated commercial adoption across pharma, academic research and diagnostics.
-
Summa Equity Acquires Majority Stake in myneva
June 30, 2021
Software
Summa Equity Fund II has acquired a majority stake in myneva, a Hamburg‑based European software provider offering SaaS solutions for the social care sector. myneva serves around 2,000 customers across six European countries, has approximately 220 employees and €30m in revenue; Summa intends to support further digitization, international expansion and continued growth.
-
Summa Equity Acquires Majority Stake in Intix
March 1, 2022
Financial Services
Summa Equity Fund III has acquired a majority stake in Intix, a Mechelen-based Belgian fintech that provides a transaction and compliance insight platform for banks and financial institutions. The investment will support Intix's growth and product innovation in real-time transaction monitoring and compliance while keeping the founders on board.
-
Summa Equity Acquires Majority Stake in STIM AS
March 4, 2024
Agriculture
Summa Equity (via Summa Equity Fund III) has made a majority investment in Norwegian fish-health products and services leader STIM AS, partnering with founder Jim‑Roger Nordly. The investment will support STIM’s product development, new growth verticals and international expansion of its advisory and service offerings in aquaculture.
-
Summa Equity Acquires Majority Stake in Logpoint
March 2, 2023
Cybersecurity
Summa Equity is acquiring a majority stake in Logpoint, the Copenhagen-based cybersecurity vendor, via its EUR 2.3bn Fund III to build a European cybersecurity powerhouse. The transaction leaves Yttrium as a significant minority shareholder and is subject to final regulatory approval (expected Q2 2023).
-
Summa Equity Acquires Majority Stake in Bollegraaf Group
September 17, 2024
Manufacturing
Stockholm-based impact investor Summa Equity has acquired a majority stake in Netherlands-headquartered Bollegraaf Group, a global provider of turnkey recycling and waste‑sorting solutions. Summa is investing from its EUR 2.3 billion Fund III to accelerate Bollegraaf’s growth, expand innovation in mechanical recycling technologies and drive the transition to a circular economy; the seller is Capital A Investment Partners and the deal is expected to close following regulatory approvals in October 2024.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.